J. A. Harder

687 total citations
14 papers, 535 citations indexed

About

J. A. Harder is a scholar working on Cognitive Neuroscience, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. A. Harder has authored 14 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cognitive Neuroscience, 7 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. A. Harder's work include Memory and Neural Mechanisms (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). J. A. Harder is often cited by papers focused on Memory and Neural Mechanisms (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). J. A. Harder collaborates with scholars based in United Kingdom and United States. J. A. Harder's co-authors include R.M. Ridley, Craig F. Ferris, Marcelo Febo, Praveen Kulkarni, Tara Messenger, John M. Sullivan, H. F. Baker, C. J. Maclean, Paul T. Francis and Janet Alder and has published in prestigious journals such as Journal of Neuroscience, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

J. A. Harder

14 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. A. Harder United Kingdom 11 310 222 144 130 65 14 535
Alexandra Barbelivien France 17 385 1.2× 350 1.6× 158 1.1× 158 1.2× 196 3.0× 33 792
JH Krystal United States 6 557 1.8× 173 0.8× 101 0.7× 287 2.2× 59 0.9× 8 795
Emanuele Seu Italy 15 370 1.2× 289 1.3× 98 0.7× 155 1.2× 118 1.8× 16 694
S. Michalíková United Kingdom 11 243 0.8× 176 0.8× 156 1.1× 88 0.7× 172 2.6× 14 625
Melvin Lyon United States 14 260 0.8× 170 0.8× 105 0.7× 114 0.9× 57 0.9× 19 606
Phillip M. Baker United States 15 445 1.4× 353 1.6× 89 0.6× 169 1.3× 50 0.8× 22 709
Nurith Amitai United States 12 395 1.3× 240 1.1× 97 0.7× 174 1.3× 59 0.9× 16 581
Concepción Vinader‐Caerols Spain 17 263 0.8× 182 0.8× 138 1.0× 82 0.6× 163 2.5× 38 580
Armando G. Salinas United States 13 397 1.3× 200 0.9× 77 0.5× 214 1.6× 85 1.3× 21 745
Jacqueline Penit-Soria France 11 544 1.8× 212 1.0× 87 0.6× 282 2.2× 106 1.6× 14 691

Countries citing papers authored by J. A. Harder

Since Specialization
Citations

This map shows the geographic impact of J. A. Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Harder more than expected).

Fields of papers citing papers by J. A. Harder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Harder. The network helps show where J. A. Harder may publish in the future.

Co-authorship network of co-authors of J. A. Harder

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Harder. A scholar is included among the top collaborators of J. A. Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Harder. J. A. Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Brevard, Mathew E., Jerrold S. Meyer, J. A. Harder, & Craig F. Ferris. (2006). Imaging brain activity in conscious monkeys following oral MDMA (“ecstasy”). Magnetic Resonance Imaging. 24(6). 707–714. 33 indexed citations
2.
Ferris, Craig F., Marcelo Febo, Feng Luo, et al.. (2006). Functional Magnetic Resonance Imaging in Conscious Animals: A New Tool in Behavioural Neuroscience Research. Journal of Neuroendocrinology. 18(5). 307–318. 43 indexed citations
3.
Ferris, Craig F., Praveen Kulkarni, John M. Sullivan, et al.. (2005). Pup Suckling Is More Rewarding Than Cocaine: Evidence from Functional Magnetic Resonance Imaging and Three-Dimensional Computational Analysis. Journal of Neuroscience. 25(1). 149–156. 162 indexed citations
4.
Harder, J. A. & R.M. Ridley. (2000). The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys. Neuropharmacology. 39(4). 547–552. 55 indexed citations
5.
Harder, J. A., et al.. (1998). Learning impairments induced by glutamate blockade using dizocilpine (MK‐801) in monkeys. British Journal of Pharmacology. 125(5). 1013–1018. 41 indexed citations
6.
Harder, J. A., H. F. Baker, & R.M. Ridley. (1998). The Role of the Central Cholinergic Projections in Cognition: Implications of the Effects of Scopolamine on Discrimination Learning by Monkeys. Brain Research Bulletin. 45(3). 319–326. 40 indexed citations
7.
Harder, J. A. & M.E. Kelly. (1997). The Effect of Several Putative Cognition Enhancers on a Water Maze Acquisition Deficit Produced by pCPA + Scopolamine Combination Treatment. Pharmacology Biochemistry and Behavior. 56(4). 657–661. 5 indexed citations
8.
Harder, J. A., M.E. Kelly, Christopher H.K. Cheng, & B. Costall. (1996). Combined pCPA and muscarinic antagonist treatment produces a deficit in rat water maze acquisition. Pharmacology Biochemistry and Behavior. 55(1). 61–65. 26 indexed citations
10.
Ridley, R.M., J. A. Harder, & H. F. Baker. (1996). Neurochemical Modulation of the Hippocampus in Learning, Remembering and Forgetting in Primates. PubMed. 5(4). 467–471. 8 indexed citations
11.
Harder, J. A., C. J. Maclean, Janet Alder, Paul T. Francis, & R.M. Ridley. (1996). The 5-HI1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology. 127(1-2). 245–254. 3 indexed citations
12.
Harder, J. A., et al.. (1996). The 5-HT 1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology. 127(3). 245–254. 18 indexed citations
13.
Harder, J. A., C. J. Maclean, Janet Alder, Paul T. Francis, & R.M. Ridley. (1996). The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset.. PubMed. 127(3). 245–54. 53 indexed citations
14.
Harder, J. A., C. J. Maclean, R.M. Ridley, Janet Alder, & Paul T. Francis. (1996). The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology. 127(3). 245–254. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026